Insys agrees to pay $4.45 million to resolve Illinois opioid lawsuit
Insys Therapeutics Inc has agreed to pay $4.45 million to resolve a lawsuit by Illinois' attorney general claiming it deceptively marketed an addictive fentanyl-based cancer pain drug for off-label uses. More »
